C

Charles J. Sherr

St. Jude Children's Research Hospital

ORCID: 0000-0002-5516-6206

Publishes on Cancer-related Molecular Pathways, Virus-based gene therapy research, Ubiquitin and proteasome pathways. 340 papers and 70.7k citations.

PubIndex Score94Top 6% · seniorHow it's scored

340Publications

70.7kTotal Citations

First publication: 1969First senior author: 1986

Cancer-related Molecular Pathways Virus-based gene therapy research Ubiquitin and proteasome pathways Epigenetics and DNA Methylation Microtubule and mitosis dynamics

Top publicationsby citations

CDK inhibitors: positive and negative regulators of G1-phase progression

Charles J. Sherr, Joanna Roberts|Genes & Development|1999

Cited by 6.1k

Inhibitors of mammalian G1 cyclin-dependent kinases.

Charles J. Sherr, Joanna Roberts|Genes & Development|1995

Cited by 3.3k

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Kornélia Polyák, Andrew Koff, Charles J. Sherr et al.|Genes & Development|1994

Cited by 2k

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Dawn E. Quelle, Charles J. Sherr|Genes & Development|1993

Cited by 1k

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation

Jun‐ya Kato, Charles J. Sherr, Masaaki Matsuoka et al.|Cell|1994

Cited by 729